License agreement with Northwestern University for AKV9 has been completed. October 22, 2021 By Ver_ak@va ← PreviousAKAVA Founder, Richard B. Silverman receives 2021 Tetrahedron PrizeNext →NU‑9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone
